Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Hamas propaganda expert explains Israel's internal conflicts influenced Hamas's Oct. 7 assault- Mechanical Sidekick d: A Survey of \Elements and Execution d\ Cell phone
- Avoid Large Crowds In Bali & Swim At This Peaceful Waterfall With A Gorgeous, Natural Pool
- Becoming amazing at Arranging Pay Raises
- CDC vaccine panel delays vote to stop recommending hepatitis B shot at birth
- 6 U.S. States for Climbing
- Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says
- Culinary Joys: Investigating Connoisseur Cooking at Home
- Make your choice for the bird that catches your heart!
